Lonza Group.
Swiss chemical and pharmaceutical company headquartered in Basel, Switzerland
Lonza Raises Midterm Growth Targets, Backs 2026 Outlook
Lonza set a ROIC goal of 2–3x WACC and lifted mid-term organic sales growth to 10–13% with high-thirties EBITDA margins, while backing 11–12% 2026 CER sales growth.
Business · 8 sources · 4dRead itThe journal
Open the journal →The conversation starts in the journal — be the first to post.
About Lonza Group
Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector.
Everything about Lonza Group →- Country
- Switzerland
- Headquarters
- Basel
- Inception
- 1897
- Website
- http://www.lonza.com/